ArticleFrontiers in oncology2021

Bispecific c-Met/PD-L1 CAR-T Cells Have Enhanced Therapeutic Effects on Hepatocellular Carcinoma.

Wei Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.